Integration of flux measurements to resolve changes in anabolic and catabolic metabolism in cardiac myocytes

Biochem J. 2017 Aug 7;474(16):2785-2801. doi: 10.1042/BCJ20170474.

Abstract

Although ancillary pathways of glucose metabolism are critical for synthesizing cellular building blocks and modulating stress responses, how they are regulated remains unclear. In the present study, we used radiometric glycolysis assays, [13C6]-glucose isotope tracing, and extracellular flux analysis to understand how phosphofructokinase (PFK)-mediated changes in glycolysis regulate glucose carbon partitioning into catabolic and anabolic pathways. Expression of kinase-deficient or phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in rat neonatal cardiomyocytes co-ordinately regulated glycolytic rate and lactate production. Nevertheless, in all groups, >40% of glucose consumed by the cells was unaccounted for via catabolism to pyruvate, which suggests entry of glucose carbons into ancillary pathways branching from metabolites formed in the preparatory phase of glycolysis. Analysis of 13C fractional enrichment patterns suggests that PFK activity regulates glucose carbon incorporation directly into the ribose and the glycerol moieties of purines and phospholipids, respectively. Pyrimidines, UDP-N-acetylhexosamine, and the fatty acyl chains of phosphatidylinositol and triglycerides showed lower 13C incorporation under conditions of high PFK activity; the isotopologue 13C enrichment pattern of each metabolite indicated limitations in mitochondria-engendered aspartate, acetyl CoA and fatty acids. Consistent with this notion, high glycolytic rate diminished mitochondrial activity and the coupling of glycolysis to glucose oxidation. These findings suggest that a major portion of intracellular glucose in cardiac myocytes is apportioned for ancillary biosynthetic reactions and that PFK co-ordinates the activities of the pentose phosphate, hexosamine biosynthetic, and glycerolipid synthesis pathways by directly modulating glycolytic intermediate entry into auxiliary glucose metabolism pathways and by indirectly regulating mitochondrial cataplerosis.

Keywords: cardiac hypertrophy; glycolysis; heart failure; metabolomics; mitochondria; stable isotope.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Animals, Newborn
  • Carbon Isotopes
  • Cells, Cultured
  • Culture Media, Serum-Free
  • Glucose / metabolism*
  • Glycolysis*
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • Hexosamines / metabolism
  • Lactic Acid / metabolism
  • Mitochondria, Muscle / enzymology
  • Mitochondria, Muscle / metabolism*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / metabolism*
  • Oligopeptides / genetics
  • Oligopeptides / metabolism
  • Pentose Phosphate Pathway*
  • Phosphofructokinase-1, Liver Type / genetics
  • Phosphofructokinase-1, Liver Type / metabolism*
  • Point Mutation
  • Pyrimidines / metabolism
  • Pyruvic Acid / metabolism
  • Rats, Sprague-Dawley
  • Recombinant Fusion Proteins / metabolism
  • Uridine Diphosphate / analogs & derivatives
  • Uridine Diphosphate / metabolism

Substances

  • Carbon Isotopes
  • Culture Media, Serum-Free
  • Hexosamines
  • Oligopeptides
  • Pyrimidines
  • Recombinant Fusion Proteins
  • enhanced green fluorescent protein
  • Green Fluorescent Proteins
  • Lactic Acid
  • Uridine Diphosphate
  • Pyruvic Acid
  • FLAG peptide
  • Phosphofructokinase-1, Liver Type
  • phosphofructokinase-1 subunit, type L
  • Glucose